GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF COMB 深 滬
等待開盤 12-18 09:30:00 美东时间
22.81
+0.273
+1.21%
華盛通- 最 高22.81
- 今 開22.695
- 成交量 7720股
- 最 低 22.681
- 昨 收 22.537
- 總市值 8439.70万
- 52周最高 23.57
- 市盈率 靜 --
- 換手率 0.21%
- 52周最低 19.7093
- 委 比 -60.00%
- 總股本 370.00万
- 歷史最高 27.097
- 量 比 0.07
- 振 幅 0.57%
- 歷史最低 4.4999
- 每 手 1
- 風險率 0.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FULTON FINANCIAL CORPORATION AND BLUE FOUNDRY BANCORP COMBINING IN ALL-STOCK MERGER
Transaction Expands Fulton's Presence in Highly Attractive New Jersey Markets LANCASTER, Pa. and RUTHERFORD, N.J., Nov. 24, 2025 /PRNewswire/ -- Fulton Financial Corporation (Nasdaq: FULT) (...
11-24 21:45
MediciNova Completes Patient Enrollment In Phase 2/3 Clinical Trial, COMBAT-ALS For Treatment Of Amyotrophic Lateral Sclerosis
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the successful completion of patient
09-22 20:09
MediciNova Issues Shareholder Update; Secures $30M SEPA To Advance R&D As COMBAT-ALS Trial Hits Enrollment Target; NIH-Funded EAP And MN-001 Diabetes Study Near Completion
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the "Company"), provides a shareholder
09-08 21:12
Club Offers Released on June 19, 2025
TORONTO, June 19, 2025 /PRNewswire/ -- Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces the release of Club Offers for Club Members. Rigorously vetted and negotiated for...
06-19 20:02
币安决定于2025年3月28日11:00停止交易并下架AERGO、AST等币种
博链财经BroadChain获悉，币安决定于2025年3月28日11：00停止交易并下架以下币种：Aergo（AERGO）、AirSwap（AST）、Bu...
03-21 17:32
AI味儿最浓的一届AWE，家电厂商都有哪些花活儿？
作者丨习翔宇 编辑丨苏建勋 邱晓芬 3月14日，AWE2024（中国家电及消费电子博览会）在上海新国际博览中心开幕。36氪连逛两天，走遍全场13个展馆，发现今年...
2024-03-16 11:09
Hikma announces US launch of COMBOGESIC® IV
Offers health care providers a new multimodal approach to adult pain management LONDON, Feb. 5, 2024 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical compa...
2024-02-05 20:00
Jaypirca® (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor
The first and only non-covalent (reversible) BTK inhibitor, Jaypirca has been shown to extend the benefit of BTK inhibition In the BRUIN Phase 1/2 trial, adult patients with CLL/SLL who have...
2023-12-02 06:22
GIANT BIOGENE(2367.HK):PIONEER IN RECOMBINANT COLLAGEN MARKET
Giant Biogene is a leader in the professional skin treatment industry in China,...
2023-11-27 14:42
